image
AnaptysBio, Inc. ANAB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 21.24
0.341 %
$ 651 M
Market Cap
-4.03
P/E
Price Target Average
123.90%
Revenue Forecast Estimate
10.29%
EBIT Estimate
0.44%
Net Income Estimate
1.58%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets AnaptysBio, Inc.
image
Wall Street analysts predict an average 1-year price target for ANAB of $47.6 , with forecasts ranging from a low of $19 to a high of $90 .
ANAB Lowest Price Target Wall Street Target
19 USD -10.55%
ANAB Average Price Target Wall Street Target
47.6 USD 123.90%
ANAB Highest Price Target Wall Street Target
90 USD 323.73%
Price
Max Price Target
Min Price Target
Average Price Target
909080807070606050504040303020201010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart ANAB

image
$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ANAB

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ANAB

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029